Summary |
|
|||||||||||||
Transgene origin |
|
|||||||||||||
Transgene description |
|
|||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
Expression |
|
|||||||||||||
Find Mice (IMSR) |
|
|||||||||||||
Notes |
Line 9956, which expresses the transgene product at a lower level than line 9813, was also produced.
Transgenic mice express human A53T variant alpha-synuclein under the direction of the mouse Thy1 promoter. These mice display axonal degeneration in spinal roots, denervation of neuromuscular junctions, inclusions and reactive gliosis in spinal cord and brainstem, and decrease in rotarod performance after 40 days of age. |
|||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|